Skip to main content
Find Faculty / Michael Williams

Contact Information:


Michael Williams

4208D Engineering Building III
NC State University
Raleigh, NC 27695-7115
(919) 515-0954

mswilli8@ncsu.edu

Research Areas:
  • Biomedical Microdevices
  • Regenerative Medicine
Education:
  • California Polytechnic State University, San Luis Obispo

Bio

Prior to joining UNC-NCSU Joint Department of BME Williams served as Visiting Scientist in the Langer Lab at MIT’s Koch Institute for Integrative Cancer Research, Industry Advisory Board Member at the University of North Carolina and North Carolina State University Joint Department of Biomedical Engineering, Chief Technology Officer at Synecor, LLC where he co-founded multiple companies, Chief Technology Officer at Synergy Life Sciences and Vice President of Science and Technology at Medtronic AVE. While at Medtronic, Williams founded and was the divisional VP and General Manager of the Neurovascular Technologies Division that was responsible for bringing to market the world’s first neurovascular stent and delivery system. He was also responsible for the vascular divisions pre-clinical, biological and materials research. Before joining AVE, Williams held senior management and R&D engineering positions at Microvena Corporation, Guidant’s Advanced Cardiovascular Systems and Baxter Healthcare’s Pharmaseal Division.

Williams also serves as an adjunct faculty member in the School of Science, Technology and Health Sciences at Eastern Oregon University.

In his work Williams has been on the forefront of multiple new technology frontiers including pulsed antigen releasing single administration multi-dose vaccine delivery for veterinary immunization, therapeutic live cell immuno-isolation, metallic stents, bioresorbable drug delivery stents, minimally invasive surgical systems, implantable neuromodulation devices for CHF/ADHF, vascular brachytherapy, controlled release drug delivery, iontophoretic drug delivery, photodynamic therapy, vascular gene therapy and neurovascular interventions.

Educated at California Polytechnic State University, San Luis Obispo Williams holds 64 issued patents, has coauthored a book chapter as well as several technical papers and abstracts and has been an invited speaker at various technical, scientific and clinical conferences.

Research Interests

Interventional immunology
Lymphatic therapeutics
Reverse cholesterol transport
Directed lymphangiogenesis
Treatment of inflammatory diseases (RA, IBD, Atherosclerosis)
Intradermal vaccine, drug and micronutrient delivery systems for veterinary and human use
One Health